tubal phenolsulfonphthalein patency test
The fallopian tube phenolsulfonate test can be used to inject the methylene blue into the uterine cavity. If it can enter the abdominal cavity through the fallopian tube, the methylene blue can be observed from the fallopian tube into the abdominal cavity under laparoscopy. Basic Information Specialist classification: gynecological examination classification: ultrasound Applicable gender: whether women are fasting: fasting Analysis results: Below normal: Normal value: no Above normal: negative: The colorimetric concentration is from 90% to 100%. Positive: Mainly used for the diagnosis of fallopian tube obstruction, colorimetric concentration of 60%-80% means incomplete blockage, 50% means complete blockage. Tips: Check the menstrual clean 3d-7d, and pay attention to the disinfection and cleaning of the vulva and empty the bladder, forbidden room. Normal value The colorimetric concentration is from 90% to 100%. Clinical significance Abnormal results: mainly used for the diagnosis of tubal obstruction, colorimetric concentration of 90%-100%, indicating tubal patency; 60%-80% means incomplete obstruction, 50% means complete obstruction. People who need to check: 1. Primary or secondary infertility, suspected tubal obstruction. 2. The effect of surgery after tubal ostomy or adhesion separation. 3. After the sterilization of tubal ligation, occlusion, etc., check the surgical results. 4. After the fallopian tube recanalization, the surgical effect is checked and the anastomosis adhesion can be prevented. 5. Treatment of mild fallopian tube obstruction. Positive results may be diseases: tubal infertility, complications after tubal ligation, tubal obstruction infertility, fallopian tube obstruction Taboo before inspection: 1. Fasting for 12 hours. 2. Do not have sex before 3 days. 3. Test at 3d-7d after menstruation is clean. 4, before the inspection should pay attention to the disinfection and cleaning of the vulva. 5. Empty the bladder before examination. Requirements for inspection: 1. After the test, the patient was banned from the same room and bathed for 2 weeks. 2. Apply antibiotics to prevent infection after the test. 3, lower abdominal pain may occur when injecting liquid, at this time not necessarily too often, after the medical staff can correctly handle it. 4, drink warm water 200ml-300ml. Inspection process 1. The test is carried out 3d-7d after the menstruation is clean. 2. After the patient emptys the bladder, take the bladder lithotomy position and do a routine gynecological examination to understand the location, size and surrounding tissue of the uterus. 3. Routine disinfection vulva, vagina, sterilized hole towel, open the vagina with vaginal speculum under aseptic operation, expose the cervix, and disinfect with iodine and ethanol. 4. Use the cervical clamp to clamp the anterior lip of the cervix and use the uterine probe to detect the depth and direction of the uterus. 5. Fix the rubber stopper or metal plug on the uterine catheter to a position 2 cm below the depth of the uterine cavity, and then put the catheter into the uterine cavity to make the rubber stopper of the external cervix close to prevent the injected liquid from overflowing. 6. Phenolsulfonate, 1 ml (6 mg) was added to 10 ml of warm saline or water for injection, and was injected into the uterine cavity via a catheter. After 10 minutes, the uterine catheter was removed. 7. Patients with warm water 200ml-300ml. 8. 2 ml of phenolsulfonate (12 mg), add 20 ml of warm saline or water for injection, inject into the uterine cavity through the catheter, and remove the catheter after 10 min. 9. After half an hour, the patient was urinated, collected in a container, and dropped 3 to 5 drops of 20% sodium hydroxide, and then colorimetrically compared with a colorimeter. Not suitable for the crowd Inappropriate crowd: 1, acute or subacute pelvic inflammatory disease. 2, severe cervical erosion, chronic cervicitis with purulent secretions. 3, fungal, gonococcal or trichomonas vaginitis. 4, pregnancy, menstrual period, irregular uterine bleeding. 5, severe systemic diseases, heart disease, severe infectious diseases, respiratory insufficiency, liver and kidney dysfunction, bleeding disorders, diffuse peritonitis. 6, sexual intercourse within 3 days. Adverse reactions and risks Nothing.
The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.